MONTREAL--(BUSINESS WIRE)-- At the 2011 Annual Meeting of the Canadian Association for Clinical Microbiology and Infectious Diseases (CACMID), the companies i2A Canada and Bruker Ltd. announced ...
Bruker Corporation BRKR recently announced a collaboration and quality agreement with the medical device company, Accelerate Diagnostics Inc. AXDX. The agreement enables the validation of Bruker’s ...
The new MALDI Tissuetyper based on the rapifleX instrument re-defines the key performance measures for MALDI imaging and allows for completely new projects and measurement strategies. The rapifleX ...
TUCSON, Ariz., Nov. 27, 2023 /PRNewswire/ -- Accelerate Diagnostics, Inc. (AXDX) an innovator of rapid in vitro diagnostics in microbiology, announced the signing of a collaboration and quality ...
Innovative timsTOF platform combined with extreme MALDI PharmaPulse speed and robustness for unbiased, deep HTS and uHTS (ultra-high-throughput screening) Trapped Ion Mobility Spectrometry (TIMS): ...
Watch this live demo from Bruker's lab to see the MALDI MS polymer analysis workflows from beginning to end. We will showcase several different Bruker MALDI instruments featuring advanced new ...
neofleX is a versatile, high-performance, and easy-to-use multiomics MSI system for biopharma, translational and clinical researchers neofleX Imaging Profiler MALDI-TOF/TOF with proprietary smartbeam ...
At the annual IDWeek meeting, Bruker announced the U.S. Food and Drug Administration (FDA) clearance of Claim 7 and Claim 8 for its MALDI Biotyper ® CA System, marking a significant advancement in ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback